CTA
CHE icon

Carillon Tower Advisers’s Chemed CHE Stock Holding History

Carillon Tower Advisers’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100,708
Closed -$40.3M – 465
2020
Q1 		$40.3M Hold
100,708
– – 0.4% 80
2019
Q4 		$44.2M Hold
100,708
– – 0.3% 116
2019
Q3 		$42.1M Buy
+100,708
New +$41.1M 0.29% 121

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carillon Tower Advisers's CHE Position: Q2 2020 in Review

Carillon Tower Advisers sold out of Chemed (CHE) in Q2 2020, closing a stake of 100,708 shares — an estimated $40.3M sold.

Carillon Tower Advisers first reported a position in CHE in Q3 2019 and held it in 3 quarters. The position peaked at $44.2M in Q4 2019. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2020.

  • Carillon Tower Advisers reported no remaining Chemed position as of Q2 2020 after selling out during the quarter.
  • Carillon Tower Advisers sold 100,708 Chemed shares in Q2 2020, an estimated $40.3M.
  • Carillon Tower Advisers first reported a position in Chemed in Q3 2019 and held it in 3 quarters.
  • Carillon Tower Advisers's Chemed position peaked at $44.2M in Q4 2019.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2020.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.